| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/QCO.0B013E32834EF5D9 |
| P698 | PubMed publication ID | 22156900 |
| P2093 | author name string | Tomas Doyle | |
| Anna Maria Geretti | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 17-25 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Current Opinion in Infectious Diseases | Q15724406 |
| P1476 | title | Low-level viraemia on HAART: significance and management | |
| P478 | volume | 25 |
| Q36548103 | A Case of Long-Term Seronegative Human Immunodeficiency Virus (HIV) Infection: The Importance of the Humoral Response to HIV |
| Q40857953 | Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART? |
| Q26768632 | Barriers to a cure for HIV in women |
| Q39197846 | CD34+ hematopoietic stem cells support entry and replication of poliovirus: a potential new gene introduction route |
| Q40692788 | CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF |
| Q36798408 | Cell-associated HIV RNA: a dynamic biomarker of viral persistence |
| Q35111879 | Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells |
| Q42230298 | Comparing HIV viral load assays and frequency of low level virological rebound in clinical practice |
| Q40166933 | Comparison of droplet digital PCR and seminested real-time PCR for quantification of cell-associated HIV-1 RNA. |
| Q49711913 | Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India |
| Q40668682 | Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia. |
| Q45015094 | Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial |
| Q52672845 | Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy. |
| Q35861475 | Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment |
| Q35057427 | HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels |
| Q34410446 | HIV cure research: advances and prospects |
| Q38380240 | HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy. |
| Q40309618 | HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimens |
| Q34482990 | Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL |
| Q51067090 | Is HIV post-exposure prophylaxis required following occupational exposure to a source patient who is virologically suppressed on antiretroviral therapy? |
| Q28550552 | Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study |
| Q39178197 | Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy. |
| Q41276669 | Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice |
| Q34801630 | Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation |
| Q36086379 | Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing |
| Q38982524 | Pokeweed antiviral protein alters splicing of HIV-1 RNAs, resulting in reduced virus production |
| Q40303602 | Relevance of retrovirus quantification in cerebrospinal fluid for neurologic diagnosis |
| Q33566570 | Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41. |
| Q38203913 | The potential advantages of digital PCR for clinical virology diagnostics |
| Q36460329 | Viral diagnostics in the era of digital polymerase chain reaction |
Search more.